WINDTREE THERAPEUTICS INC /DE/ Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Windtree Therapeutics Inc /De/ quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Windtree Therapeutics Inc /De/ Debt-to-equity for the quarter ending September 30, 2024 was 321 %, a 2.17% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 321 +6.82 +2.17% Sep 30, 2024
Q2 2024 304 +52.6 +20.9% Jun 30, 2024
Q1 2024 267 +44.6 +20.1% Mar 31, 2024
Q4 2023 389 +237 +156% Dec 31, 2023
Q3 2023 315 +201 +177% Sep 30, 2023
Q2 2023 251 +160 +177% Jun 30, 2023
Q1 2023 223 +149 +205% Mar 31, 2023
Q4 2022 152 +91.2 +150% Dec 31, 2022
Q3 2022 114 +55.2 +94.5% Sep 30, 2022
Q2 2022 90.8 +34.7 +61.9% Jun 30, 2022
Q1 2022 73 +18.2 +33.3% Mar 31, 2022
Q4 2021 60.8 +2.58 +4.43% Dec 31, 2021
Q3 2021 58.4 +0.99 +1.73% Sep 30, 2021
Q2 2021 56.1 -7.62 -12% Jun 30, 2021
Q1 2021 54.8 -16 -22.6% Mar 31, 2021
Q4 2020 58.2 -16.9 -22.5% Dec 31, 2020
Q3 2020 57.4 -22.8 -28.4% Sep 30, 2020
Q2 2020 63.7 -50.3 -44.1% Jun 30, 2020
Q1 2020 70.8 -158 -69.1% Mar 31, 2020
Q4 2019 75.1 +817 Dec 31, 2019
Q3 2019 80.2 +189 Sep 30, 2019
Q2 2019 114 +225 Jun 30, 2019
Q1 2019 229 +343 Mar 31, 2019
Q4 2018 -742 -621 -511% Dec 31, 2018
Q3 2018 -109 +16.5 +13.1% Sep 30, 2018
Q2 2018 -111 +28.8 +20.6% Jun 30, 2018
Q1 2018 -114 +54 +32.2% Mar 31, 2018
Q4 2017 -121 +98 +44.7% Dec 31, 2017
Q3 2017 -126 +321 +71.8% Sep 30, 2017
Q2 2017 -140 -2.68K -106% Jun 30, 2017
Q1 2017 -168 -953 -121% Mar 31, 2017
Q4 2016 -219 -648 -151% Dec 31, 2016
Q3 2016 -446 -744 -250% Sep 30, 2016
Q2 2016 2.54K +2.32K +1027% Jun 30, 2016
Q1 2016 785 +661 +532% Mar 31, 2016
Q4 2015 429 +342 +393% Dec 31, 2015
Q3 2015 298 +229 +332% Sep 30, 2015
Q2 2015 225 +153 +212% Jun 30, 2015
Q1 2015 124 +49.6 +66.4% Mar 31, 2015
Q4 2014 87.1 -7.94 -8.36% Dec 31, 2014
Q3 2014 69 -67.1 -49.3% Sep 30, 2014
Q2 2014 72.3 -25.9 -26.4% Jun 30, 2014
Q1 2014 74.7 +2.24 +3.09% Mar 31, 2014
Q4 2013 95 +46.2 +94.5% Dec 31, 2013
Q3 2013 136 +79.6 +141% Sep 30, 2013
Q2 2013 98.2 +32.6 +49.8% Jun 30, 2013
Q1 2013 72.4 -27.9 -27.8% Mar 31, 2013
Q4 2012 48.9 Dec 31, 2012
Q3 2012 56.5 Sep 30, 2012
Q2 2012 65.6 Jun 30, 2012
Q1 2012 100 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.